Posted On: 12/31/2012 8:09:46 PM
Post# of 72440
| Kevetrin | Cancer | Phase 1 |
| Prurisol | Psoriasis | Phase 2/3 505(b)(2) |
| KM 391 | Autism | Preclinical |
| KM 227 | Arthritis | Preclinical |
| KM 278 | Arthritis/Asthma | Preclinical |
| KM 3174 | Cancer | Early R&D |
| KM 362 | MS/ALS/Park | Early R&D |
| KM 732 | Hypertensive emergency | Early R&D |
(0)
(0)Scroll down for more posts ▼
